Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Maqin Granules
- Development stage
- Unknown
- Lead developer
- Sichuan Academy of Chinese Medical Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Maqin Granules is a Traditional Chinese Medicine (TCM) compound developed by the Sichuan Academy of Chinese Medicine Sciences for the treatment of respiratory conditions, specifically post-infectious cough (PIC) and cough variant asthma (CVA). The formulation is based on the TCM principles of clearing heat, ventilating the lungs, and relieving cough, and it primarily contains extracts from *Ephedra herba* (Ma Huang) and *Scutellariae Radix* (Huang Qin). Maqin Granules is designed to address the "wind-heat invading the lung" syndrome, characterized by persistent coughing following a respiratory infection. Mechanistically, the drug exerts antitussive and anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as IL-4 and IL-5, reducing serum IgE levels, and decreasing airway hyperresponsiveness. It has progressed to Phase 3 clinical trials in China for the treatment of post-infectious cough.
- Brand names
- Maqin Granules
- Other names
- Maqin Keli麻芩颗粒
02
Targets
IL-4 (Interleukin 4)IL-5 (Interleukin 5)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)IgE (Immunoglobulin E)
Beyond the preview
Go deeper on Maqin Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Maqin Granules.